15-12G ·Filed Apr 2, 2026

EXAS

EXACT SCIENCES CORP
BEARISH
Impact 7/10
Horizonimmediate Processed6mo ago SEC0001193125-26-138856
Deregistration
Actionable Insight ▼ Bearish

Traders should anticipate reduced liquidity and limited financial disclosures going forward. Consider exiting positions if holding relies on public information; monitor OTC markets if shares continue trading. A single holder suggests a potential private takeover—watch for related-party transactions or delisting from Nasdaq.

DirectionBearish
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligations, citing fewer than 300 holders of record for its common stock and convertible notes. This 'going dark' move follows a significant reduction in shareholder base, likely due to a consolidation or buyout, and will reduce transparency and liquidity for remaining investors.

Key Facts

  • Exact Sciences Corporation (EXAS) filed Form 15-12G to terminate registration under Section 12(g) of the Exchange Act.
  • As of April 2, 2026, the company reported only 1 holder of record for its common stock.
  • Convertible senior notes due 2027 and 2028 each have fewer than 300 holders of record.
  • The filing invokes Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i), allowing termination of reporting when shareholder thresholds are no longer met.
  • The company will no longer be required to file periodic reports (10-K, 10-Q) or current reports (8-K).

Financial Impact

Loss of public reporting and reduced market transparency; no direct financial cost but significant reduction in investor access to information.

transparencyliquidityshareholder baseregulatory compliance costs

Risk Factors

  • Loss of transparency and difficulty in valuation due to lack of public filings.
  • Reduced liquidity as shares may move to OTC or cease trading altogether.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
15-12G Filing (Primary)0001193125-26-138856
Document: 0001193125-26-138856-index-headers.html0001193125-26-138856
Document: 0001193125-26-138856-index.html0001193125-26-138856
Document: 0001193125-26-138856.txt0001193125-26-138856
4 reports for EXAS
Performance horizon
Filters
Rows
Reports for EXAS — sortable, filterable
TypeNow
Jul 29, 2026
9w ago
Court Ruling
NEUTRAL ★ 2/10
—awaiting T+5——
Jun 12, 2026
16w ago
Institutional Cluster
BULLISH ★ 5/10
—awaiting T+5——
Apr 2, 2026
26w ago
15-12G
BEARISH ★ 7/10
—awaiting T+5——
Feb 28, 2026
30w ago
Institutional Cluster
MIXED ★ 7/10
$103.35 $103.73▲ +0.37%▲ +1.58%—
Showing 4 of 4

US Market Status

Market Open — Closes in 1h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access